Team photo
Vidya Mave with text quote
Pune Team
Union 2023 Conference
Paediatric TB: An Overview (India)
1
2
3
4
5
December 16, 2023

Director Dr. Nishi Suryavanshi, said, “One to Three HP' trial will generate scientific evidence for ultra-short-term TB preventive regimens. This may improve the TB prevention guideline system and policy in India. In turn, this study will help expand medical research on TB-HIV.

November 20, 2023

Two clinical trials show how Levofloxacin, given once daily to children over six months, prevented infection in five-year-olds exposed to MDR-TB by 56 per cent and in adolescents by 45 per cent.

December 14, 2023

For World AIDS Day, BJGMC CRS), Pune, hosted a discussion on six major HIV related studies.

November 9, 2023

CIDI was in Paris for The Union Conference on Lung Health 2023! Check out what CIDI faculty and Johns Hopkins India Partners spoke about at the sessions listed!

June 26, 2023

Video: Shedding Light on Pediatric TB in India

DEVELOPMENTS NEWS ENGAGE
Amita Gupta, MD, MHS

Deferral of maternal isoniazid preventive therapy to early postpartum had no effect on infant tuberculosis acquisition in our trial population, regardless of the diagnostic test used.

Mehta and Lucas headshots

The findings by Drs. Shruti Mehta, Gregory Lucas and colleagues show population-specific interventions and routine surveillance are need to facilitate HIV elimination.

Dr. Vidya Mave and colleagues concluded considerable intrahost mycobacterium tuberculosis mutation rates were present at recurrence among patients with diabetes mellitus. 

People with a sign for World TB Day

BJGMC-JHU Clinical Research Site (CRS) in Pune hosted 400+ engaging panel discussions, interactive outreach programs, and impactful awareness campaigns for World TB Day 2024.

Vidya Mave

The study ‘One to Three’ will compare the treatment completion of daily dose of Rifapentine and Isoniazid for a month (1HP) to the weekly dose of Rifapentine and Isoniazid for three months (3HP) in persons living with HIV in Pune.

Pune Team

For World AIDS Day, BJGMC CRS), Pune, hosted a discussion on six major HIV related studies.

Tuberculosis bacteria

The Improved Management with Antimicrobial Agents Isoniazid Rifampicin Linezolid for TBM (IMAGINE-TBM) trial will compare a six-month regimen of four drugs with the nine-month, standard-of-care regimen for TBM. 

CIDI team at a table

Check out the photo gallery from CIDI at the 2023 Union Conference on Lung Health.

Union 2023 Conference

CIDI was in Paris for The Union Conference on Lung Health 2023! Check out what CIDI faculty and Johns Hopkins India Partners spoke about at the sessions listed!